Bone Biologics Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$0.67

+0.02 (+2.48%)

As of Aug 13, 10:19 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +3,042.5% upside

Low Target $14.35

Average Target $21.19

High Target $22.63

Current Price $0.67

Current
$0.67

Target
$21.19

$14.35 $21.19 avg $22.63

Scenario Analysis

Bear Case

$14.35

2,028.1%

Low target

Base Case

$21.19

+3,042.5%

Avg target

Bull Case

$22.63

+3,256.1%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$4.13

-83.7% from high

52-Week Low

$0.83

+-18.8% from low

Target vs 52W High

$21.19

+413.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.2%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.8%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.8%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.8%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.6%